Haritaki: Traditional Uses, Dosage, Evidence & Safety

TL;DR

Haritaki (Terminalia chebula) is one of Ayurveda's oldest fruit drugs: and one-third of Triphala. Traditional uses span digestion, cough, and rejuvenation. Human evidence: three small RCTs (78–110 participants) suggest possible benefits for uric acid levels, exercise-related knee discomfort, and gum health. All tested proprietary extracts, not traditional powder. Short-term use looks well tolerated.

(54 words. Sources: Usharani et al. 2016, pilot RCT; Lopez et al. 2017, RCT; mouth-rinse RCT, n=78.)

What it is

Haritaki is the dried fruit of Terminalia chebula Retz., a tree of South Asia in the Combretaceae family. The Ayurvedic Pharmacopoeia of India (Part I, Volume I) defines the official drug as the pericarp of the mature fruit (Tier 1: API Pt. I Vol. I, Government of India; monograph reproduction). It is one of the three fruits of the classic formula Triphala: equal parts haritaki, bibhitaki, and amalaki (Triphala composition review). The API lists tannins, anthraquinones, and polyphenolic compounds among its constituents (monograph). A review of its classical profile notes the traditional saying, attributed to Charaka, that while even a mother may err toward a child, haritaki can do no harm (IJPBA review): a traditional claim of gentleness, not a scientific one.

Traditional use

The API assigns haritaki five tastes (sweet, sour, pungent, bitter, astringent), light and dry qualities, hot potency, sweet post-digestive effect, and rasayana (rejuvenative) action (monograph). Its classical therapeutic indications in the API span digestive complaints (appetite loss, piles, constipation, abdominal distension and abdominal disorders), respiratory complaints (cough, breathing difficulty), fever states, edema, anemia, urinary disorders, head complaints, and cardiac complaints (monograph): these are pharmacopoeial and classical claims, not clinical evidence. Key classical formulations include Triphala Churna, Abhayarishta, Agastya Haritaki Rasayana, Citraka Haritaki, and Dasamula Haritaki (monograph). Note: trials of Triphala as a formula do not prove haritaki's individual effects.

What modern research says

Uric acid (hyperuricemia)

In a 24-week, randomized, double-blind, placebo- and positive-controlled pilot trial of 110 adults with asymptomatic hyperuricemia (CTRI Ref/2014/09/007548), a standardized aqueous fruit extract (AyuFlex®, Natreon) at 500 mg twice daily significantly reduced serum uric acid versus baseline (P<0.01): roughly half the reduction seen with the same company's bibhitaki extract at 500 mg twice daily, and less than the active comparator febuxostat (Usharani et al., 2016). Participants with gout flares were excluded, so this does not establish haritaki as a gout treatment; the authors called the formulation well tolerated and called for confirmatory studies (Usharani et al., 2016). Product-specific results: this was a proprietary extract standardized to ≥39% chebulinic and chebulagic acids plus low-molecular-weight hydrolysable tannins: not traditional powder (Usharani et al., 2016).

In a randomized, double-blind, placebo-controlled 84-day trial of 105 healthy overweight adults (NCT02589249), the same standardized extract (AyuFlex®) at 250 mg or 500 mg twice daily improved exercise-related knee discomfort, knee function scores (mKOOS/mWOMAC), whole-body joint function, and 6-minute-walk distance and post-walk discomfort versus placebo. No adverse events were reported and safety biomarkers stayed within normal ranges (Lopez et al., 2017: PubMed; full text). Participants had no resting knee pain, this was not an osteoarthritis-treatment trial, and differences between the two doses were mostly non-significant (Lopez et al., 2017: PubMed). Again, results apply to the proprietary extract, not generic haritaki powder.

Oral health (mouth rinse)

A double-blind, randomized, three-arm trial of 78 participants compared a 10% T. chebula mouth rinse used twice daily for two weeks against 0.12% chlorhexidine and saline (PubMed). Plaque and gingival parameters improved with the haritaki rinse, with no significant difference from chlorhexidine (PubMed). This supports only the mouth-rinse preparation studied: not swallowed haritaki supplements.

What the evidence does not support (yet)

No clinical trials were identified for most classical indications (digestion, cough, rejuvenation claims). The three human trials above are small, used proprietary extracts, and tested narrow endpoints. Triphala-formula trials do not count as evidence for haritaki alone.

Dosage

The API's dose for haritaki fruit powder is 3–6 g (monograph). In clinical trials, the regimens were proprietary extracts, not powder: AyuFlex® (standardized aqueous extract) 250 mg or 500 mg twice daily for 84 days (Lopez et al., 2017), and AyuFlex® 500 mg twice daily for 24 weeks (Usharani et al., 2016). Do not equate a retail extract with the trial extract: the standardization (≥39% chebulinic/chebulagic acids and hydrolysable tannins) was trial-specific (Usharani et al., 2016). For the mouth rinse, the trial used a 10% preparation twice daily for two weeks (PubMed).

Safety & contraindications

Across the human trials identified, short-term use was well tolerated: no adverse events in the 84-day trial, with safety labs within normal ranges (Lopez et al., 2017), and no serious adverse effects in the 24-week trial, which monitored hematological, hepatic, and renal parameters (Usharani et al., 2016). Dedicated long-term safety studies were not identified. The hyperuricemia trial excluded pregnant and lactating women, people with gout flares, and those with uncontrolled hypertension or diabetes or renal or hepatic impairment (Usharani et al., 2016): so safety in those groups is unestablished. As with other herbal products, discuss use with a clinician if you are pregnant, breastfeeding, managing a condition, or taking prescription medicines.

FAQs

What is haritaki?

Haritaki is the dried fruit (pericarp) of Terminalia chebula, one of Ayurveda's classic fruit drugs and one-third of the formula Triphala (equal parts haritaki, bibhitaki, and amalaki) (monograph; Triphala composition review).

Is haritaki the same as Triphala?

No. Haritaki is one of Triphala's three fruits, alongside bibhitaki and amalaki. Trials of Triphala as a formula do not prove haritaki's individual effects (Triphala composition review).

What does haritaki do, according to research?

Three small RCTs tested a proprietary standardized extract (AyuFlex®): one 24-week pilot found reduced serum uric acid in asymptomatic hyperuricemia, one 84-day trial found improved exercise-related knee discomfort and function, and one 2-week trial found a 10% mouth rinse improved plaque and gingival measures. Results apply to those specific preparations, not traditional powder (Usharani et al., 2016; Lopez et al., 2017; mouth-rinse trial).

Does haritaki lower uric acid or treat gout?

One small 24-week pilot RCT found a standardized extract at 500 mg twice daily significantly reduced serum uric acid in adults with asymptomatic hyperuricemia. It was not a gout trial, participants with gout flares were excluded, and the authors called for confirmatory studies (Usharani et al., 2016).

How much haritaki should I take?

The API's classical dose for fruit powder is 3–6 g (monograph). Clinical trials used proprietary extracts at different doses (250–500 mg twice daily), which are not equivalent to powder. Talk to a qualified practitioner rather than extrapolating from trials.

Is haritaki safe long-term?

Short-term use was well tolerated in the identified trials (up to 24 weeks), but dedicated long-term safety studies were not identified, and pregnant or lactating women were excluded from the trials (Usharani et al., 2016; Lopez et al., 2017).

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.